Seroprevalence of Hepatitis B and C Viruses, and HIV among Antenatal Pregnant Women in Nsukka, Enugu State, Nigeria
Journal of Advances in Microbiology,
Aim: Hepatitis B and C viruses and HIV infections remain major global health concerns as causes of high morbidity and mortality in developing countries. This study aimed at determining the prevalence of HBsAg antibody, anti-Hepatitis C and HIV 1 and 2 antibodies in antenatal pregnant women in Nsukka, Nigeria.
Study Design, Area and Duration of Study: The study utilized both experimental and survey designs. Blood samples were collected from women attending antenatal clinics in two prominent hospitals in Nsukka, Enugu State, Nigeria from April to August 2016.
Methods: Blood samples from 200 pregnant women were collected into plain vacutainers and allowed to clot. The serum was separated and used to test for antibodies to the viral infections using rapid test kits with immobilized antigens following the manufacturer’s instructions. Additional information was collected using standard questionnaire.
Results: From the results, 11 (5.5%), 9 (4.5%) and 5 (2.5%) women tested positive for HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies, respectively. None of the patients was co-infected with HBV/HCV, HBV/HIV, HCV/HIV or triple infections with HBV/HCV/HIV. The mean age distribution was 28.2 years (Standard Deviation = 6.46). Marital status, age distribution and occupation were found to be statistically insignificant to the prevalence of HBsAg antibody, anti-HCV and HIV 1 and 2 antibodies (P > 0.05). Blood transfusion and history of previous surgeries were the risk factors for HBsAg and HIV 1 and 2 antibodies (P < 0.05), but not for anti- HCV (P> 0.05) among the study population. None of the respondents had body tattoo or admitted to have multiple sexual partners.
Conclusion: There are still high seroprevalence of HBV, HCV and HIV among antenatal pregnant women in the study area. Hence, there is need for integration of hepatitis screening tests among the antenatal pregnant women in the town.
- Hepatitis B surface antigen (HBsAg)
- HIV 1&2
- pregnant women.
How to Cite
Opaleye OO, Igboama MC, Ojoa JA, Odewale G. Seroprevalence of HIV, HBV, HCV and HTLV among pregnant women in Southwestern Nigeria. J. Immunoassay and Immunochem. 2015;1-30.
Eze JC, Ibeziako NS, Ikefuna AN, Nwokoye IC, Uleanya ND, Ilechukwu GC. Prevalence and risk factors for Hepatitis C and Human Immunodeficiency Virus co-Infection among children in Enugu Nigeria. Afr. J. Infect. Dis. 2014; 8(1):5-8.
Atsbaha AH, Dejen TD, Belodu R, Getachew K, Saravanan M, Wasihu AG. Sero- prevalence and associated risk factors for Hepatitis C Virus infection among voluntary counseling testing and anti-removal treatment clinic attendants in Adwa hospital, Northern Ethiopia. Biomed. Central, 2016; 1-6.
Wu SZ, Wei JL, Xu B, Wei PH, Yang Y, Qin B, Xie ZC. Detection and analysis of hepatitis C virus in HIV-infectedpatients in the Guangxi province of China. Experimental Therap. Med. 2017;13:917-23.
Naveira MCM, Badal K, Dhakal J, Mayer NA, Pokharel B, Prado RFD. Sero-prevalence of Hepatitis B and C in Nepal: A Systematic Review (1973–2017). J. Hepatol. Policy Med. 2018; 3:10.
Ogwu-Richard SO, Ojo DA, Akingbade OA, Okonko IO. Triple positive of HBsAg, Anti-HCV antibody and HIV and their influence on CD4+ lymphocyte level in the highly HIV infected population of Abeokuta, Nigeria. J. Afr. Health Sci. 2015;15(3):719-27.
Barth RE, Huijgen Q, Taljaard J, Hoepelman AM. Hepatitis B/C and HIV in Sub-Saharan Africa: An association between highly prevalent infectious diseases. A Systematic Review and Meta- Analysis. Internal J. Infect. Dis. 2010;14: 1024-31.
Opaleye OO, Igboama MC, Ojoa JA, Odewale G. Seroprevalence of HIV, HBV, HCV and HTLV among pregnant women in Southwestern Nigeria. J. Immunoassay Immunochem. 2015;1-30.
Amir F, Siddiqui ZI, Farooqui SR, Anwer A, Khan S, Azmi MI, Mehmarkhah M, Dohare R, Khan LA, Kazim SN. Impact of length of replication competent genome of Hepatitis B virus over the differential antigen secretion. J. Cell. Biochem. 2019;1-14.
Nwankiti OO, Ndako JA, Echeonwu GO, Olabode AO, Nwosuh CI, Onovoh EM, Okeke LA, Akinola JO, Duru BO, Nwagbo IO, Agada GO, Chukwuedo AA. Hepatitis C virus infection in apparently healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol. J. 2009; 6(110):1-6.
Newton OE, Ogbene OA, Okonko IO. Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria. J. Afr. Health Sci. 2015;15(3):728-36.
Ojiegbe NO, Eleje GU, Nduka EC, Okaforcha EI, Igwegbe AO. Hepatitis B virus infection and infectivity among pregnant women in Nigeria. Hong Kong J. Obstet. Gynaecol. 2018;1(1):6-13.
Mbaawuaga EM, Iroegbu CU, Ike AC. Hepatitis B virus (HBV) serological patterns in Benue State, Nigeria. Open J. Med. Microbiol. 2014;4:1-10.
Mbaawuaga EM, Iroegbu CU, Ike AC, Jombo GTA. Studies on prevalence, co-infection and associated risk factors of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) in Benue State, Nigeria. Sci. J. Public Health 2014;2(6):569-76.
Amazigo UO, Chime AB. Hepatitis-B virus infection in rural and urban populations in eastern Nigeria: prevalence of serological markers. East Afi. Med. J. 1990;67(8):539-44.
Buseri FI, Seiyaboh E, Jeremiah ZA. Surveying infections among pregnant women in the Niger Delta, Nigeria. J. Global Infect. Dis. 2010;2(3):203-11.
Omatola CA, Lawal C, Omosanyi DO, Okolo MO, Adaji DM, Mofolorunsho CK, and Bello, KE. Seroprevalence of HBV, HCV and HIV and associated risk factors among apparently healthy pregnant women in Anyigba, Nigeria. J. Viral Immunol. 2019;32:1-6.
Ifeorah IM, Bakarey AS, Adewumi MO, Faleye FOC, Akere A, Omoruyi CE, Ogunwale AO, Uttah CC, Oketade MA, Adeniji JA. Patterns of serologic markers of Hepatitis B virus infection and the risk of transmission among pregnant women in Southwestern Nigeria. J. Immunoassay Immunochem. 2017;1-26.
Olaleye OA, Kuti O, Makinde NO, Innocent UAO, Olaleye OA, Badejoko OOA, Akintayo A, Audu R. Perinatal transmission of Hepatitis B virus infection in Ile-Ife, South Western, Nigeria. J. Neonatal-Perinatal Med. 2013;6:231–36.
Anaedobe CG, Fowotade A, Omoruyi CE Bakare RA. Prevalence, socio-demographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr. Med. J. 2015;1-11.
Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh A. Seroprevalence of Hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol. J. 2012;9:1-6
Utoo BT. Hepatitis B surface antigenemia (HBsAg) among pregnant women in Southern Nigeria. Afr. Health Sci. 2013;13(4):1139-43.
Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of Hepatitis B and C viral infections among pregnant women. North Am. J. Med. Sci. 2011;3(5):238-41.
Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO. Risk factors for Hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet. Gynecol. 2010; 89:1024–28.
Olokoba AB, Salawu FK, Danburam A, Olokoba LB, Midala JK, Badung LH, Olatinwo, AWO. Hepatitis B virus infection amongst pregnant women in North-Eastern Nigeria- A call for action. Nig. J. Clin. Pract. 2011;14(1):1-4.
Okusanya BO, Aigere EOS, Eigbefoh JO, Ikheloa J. Seroprevalence and clinico-epidemiological correlates of Hepatitis C viral antibodies at an antenatal booking clinic of a tertiary hospital in Nigeria. Arch. Gynecol. Obstet. 2013;288:495-500.
Akani CI, Ojule AC, OPurum HC, John CT. Seroprevalence of HIV antibodies in pregnant Women in Port Harcourt, Nigeria. Nig. J. Med. 2006;15(1):44-8.
Okeudo C, Ezem BU, Ojiyi EC. Human Immuno-deficiency Virus antibody seroprevalence among preganat women at booking at a University Teaching Hospital in South-East Nigeria. Nig. J. Med. 2012;12(2):227-30.
Duru MU, Aluyi HAS, Anukam KC. Rapid screening for co-infection of HIV and HCV in pregnant women in Benin City, Edo State, Nigeria. Afr. Health Sci. 2009;9(3): 137-42.
Ikeme AC, Ezegwui HU, Ogbonna C. Serorevalence of Hepatitis surface antigen (HBsAg) in pregnant women in Southeast Nigeria. Trop. Doctor 2006;36:128.
Okeudo C, Ezem BU, Ojiyi EC. Maternal HCV positive seroprevalence at delivery at a tertiary hospital in South-East Nigeria. Nig. J. Med. 2010;19(4):471-74.
Akani CI, Ojule AC, OPurum HC, Ejilemele A.A. Seroprevalence of Hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Nig. J. Med. 2005;12(4):266-70.
Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population. J. Obstet. Gynaecol. 2006; 26(8):770-72.
Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ogah JI. Seroprevalence and co-infection of Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus (HSV) among pregnant women in Lokoja, North-Central Nigeria. Iran Red Crescent Med. J. 2016;18(10):1-7
Abstract View: 127 times
PDF Download: 46 times